Learn More
BACKGROUND Squamous cell carcinoma of the head and neck (SCCHN) is a common disease, which has a poor prognosis after failure of therapy. Activation of the PI3K-AKT-mTOR axis is commonly detected in(More)
A successful stem cell harvest is a prerequisite for peripheral blood SCT. We investigated the number of CD34+ cells mobilized, the number of leukaphereses needed and the expenses of treatment for 28(More)
BACKGROUND Cetuximab and docetaxel have single-agent activity in squamous cell carcinoma of the head and neck (SCCHN). The efficacy of their combination was evaluated in platinum-pretreated patients(More)
We examined the mobilization of blood monocytes (MO) with recombinant human granulocyte-macrophage colony-stimulating factor (rhuGM-CSF) with regard to the in vitro generation of MO-derived(More)